Migraine is a neurovascular disease whose prevalence is estimated at almost 20% of the adult population. Currently, there is no treatment for migraine. Millimeter stimulation of the wrist subcutaneous receptors allows the release of endorphin in the brain. MISTIC is a prospective, controlled, multicenter, double-blind, randomized study in which the research team are investigating whether millimeter stimulation of subcutaneous wrist receptors reduces the frequency of migraine crisis.
MISTIC is a multicenter, controlled, randomized, double-blind study. Eligible patients will have to report their migraine crisis in a diary during a one month pre-selection phase. Then, patients will be randomized into one of two treatment groups : * active millimeter wave emission bracelet * or placebo bracelet Patients will have to use the medical device twice a day for 3 months. The investigators will follow them for an additional 3 months to assess the persistence of the effect. Throughout the follow-up, patients will report their migraines crisis in a journal. The primary outcome will be the impact of wearing a millimeter wave bracelet for 3 months, on the number of days with migraine headaches.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
140
Wristband treatment with millimeter wave emission twice a day for 3 months.
Treatment with a millimeter wave emission wristband placebo twice a day for 3 months.
CHU Grenoble Alpes
Grenoble, France
Cabinet Mornant
Mornant, France
CH Fondation Rotschild
Paris, France
Cabinet Saint Ismier
Saint-Ismier, France
Cabinet Neuralpes
To evaluate the effects of millimeter waves applied to the wrist (MMW) on the number of days with migraine(s) at 3 months reported by the patient with episodic migraine(s) without aura.
Sequential hierarchical analysis on two criteria : * the difference in the number of days with migraine in the month prior to M3, taking into account the number of days with migraine in the month prior to inclusion, using an ANCOVA (comparison of average between the 2 groups adjusted to the initial value according to the recommendations of Vickers and Altman). * the difference in the proportion of success at M3 (reduction in the number of days with migraine by more than 50% between inclusion and M3), evaluated by the Chi2 test.
Time frame: 3 months.
To compare the evolution of migraine in terms of monthly monitoring.
Comparison of the evolution's kinetic of the number of days with migraine between the baseline (M0) and 3 months using monthly data (M1-M2-M3).
Time frame: 3 months.
To evaluate the effects of wearing a millimeter wave wristband on the severity of migraine crisis.
Headache Impact Test (named HIT-6 questionnaire) Self-Rating Scale (3 levels : mild, moderate, severe). The HIT-6 questionnaire contains 6 questions (3 first questions assessing the impact of the crisis and 3 last questions assessing the impact of the crisis). The minimum score is 36 and the maximum score is 78. It can result in a categorical use to define four grades of increasing severity: score ≤ 49: low impact; score 50-50: definite impact; score 56-59: significant impact; score ≥ 60: impact major. The higher the score, the greater the impact of headaches on quality of life.
Time frame: 3 months.
To evaluate the effects of wearing a millimeter wave wristband on the duration of migraine crisis.
Duration (in minutes) of patient-reported migraine crisis at 3 months from baseline (M0).
Time frame: 3 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Saint-Martin-d'Hères, France
CH Voiron
Voiron, France
Evaluation of the consumption of migraine crisis treatments between the 2 groups.
Number of migraine crisis treatments.
Time frame: 3 months.
To evaluate the effects of wearing the MMW wristband on the specific (i.e. migraine-related) quality of life of migraine patients (functional disability).
Evolution of the MIDAS questionnaire score between 0 and M3. The MIDAS questionnaire contains 5 questions. Description of score : the higher the number of days, the higher severity : 0 to 5 days : no severity 6 to 10 days : little severity 11 to 20 days : moderate severity more 20 days : high severity
Time frame: 3 months.
To evaluate the effects of wearing the MMW wristband on generic quality of life.
Evolution of the EQ5D-5L questionnaire score between 0 and M3. EQ-5D-5L is a standardized instrument developed by the EuroQol Group as a measure of health-related quality of lige that can be used in a wide range of health conditions and treatments. The EQ5D has 6 items intended to measure general health. The top 5 rate mobility, independence, daily activities, pain / discomfort, and anxiety / depression, and are rated according to 5 values : "No problem", "little problem", "moderate problem", "high problem" and "Incapacity". This results in an index score. The last item deals with perceived health on the day the questionnaire is filled in and uses a visual analogue scale from 0 (wors) to 100 (best health possible) (Visual Analog Scale Score)
Time frame: 3 months.
To evaluate the effects of wearing a millimeter wave wristband on associated anxiety and depressive disorders.
Evolution of the HADS questionnaire between 0 and M3. The HADS questionnaire contains 14 questions. The minimum score is 0 and the maximum score is 42. The higher the score, the depression is important : score \< 7 : no depression score 8 to 10 : doubtful depression score \> 11 : proven depression
Time frame: 3 months.
To evaluate the effects of wearing a millimeter wave wristband on the quality of sleep.
Evolution of the MOS-Sleep questionnaire between 0 and M3. The PSQI questionnaire contains 12 questions. The minimum score is 0 and the maximum score is 100 : a score of 0 corresponds to a bad quality of spleep and a score of 100 to a good quality of spleep (no difficulties).
Time frame: 3 months.
To evaluate the consumption in consultations (any type of care use) for migraine between the 2 groups.
Comparison of the costs of consultations induced by migraine (hospitalizations, medical consultations).
Time frame: 3 months.
To assess the consumption of complementary alternative migraine care between the 2 groups.
Comparison of the number of complementary alternative consultations at 3 months between the 2 groups.
Time frame: 3 months.
To evaluate the stability of the effect of wearing the MMW wristband over the long term in the intervention group.
Evaluation of the maintenance of the stability of the effect of wearing the MMW at the long term (6 months) on the number of the migraine day for the principal outcome.
Time frame: 6 months.
Adverse events.
Description of adverse events from M0 to M6 (number and type)
Time frame: 6 months.
To assess patient satisfaction with participation in the study.
Questionnaire of satisfaction with the choice of treatment at 6 months. This questionnaire of satisfaction was created by our team in order to evaluate the satifaction of patient included in this study. It contains 13 questions. No score will be calculated, only description of answers.
Time frame: 6 months.
Observance of the use of MMW wristband.
Analysis of the recorded data related to the MMW wristband. The validation of the recordings is defined by the presence of at least 2/3 of the data during the total time of use of the bracelet during 3 months.
Time frame: 3 months.
Subgroup analysis of the number of migraine day for the principal outcome in relation to patients with or without prior prophylactic treatment.
To analyse if there is a best adaptation of treatment with ou without prior prophylactic treatment (stratification on the prior prophylactic treatment variable) on the number of migraine day for the principal outocme.
Time frame: 6 months.